Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Humacyte, Inc. Director's Dealing 2025

Apr 8, 2025

33410_dirs_2025-04-08_741d1b4d-9cad-4476-89cb-8da7503c955d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2025-04-08

Reporting Person: Sebelius Kathleen (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-08 Common Stock P 50000 $1.32 Acquired 91207 Direct